company

GSK UTVIKLING AS

6509 KRISTIANSUND N

Return on Equity
−326,32 %
Current Ratio
1,03
Debt-to-Equity Ratio
190,53
Key figures (NOK)2022
Revenue0
Net Income−62 000
Total Assets6 794 000
Total Equity19 000
Income (NOK)2022
Revenue0
Expenditure83 000
Operating Profit−82 000
Financial Income0
Financial Costs2 000
Financial Balance−2 000
Earnings Before Tax−85 000
Tax−23 000
Net Income−62 000
Balance (NOK)2022
Total Fixed Assets3 541 000
Total Current Assets3 253 000
Total Assets6 794 000
Total Retained Equity−81 000
Total Equity19 000
Total Long-Term Debt3 620 000
Total Current Debt3 155 000
Total Equity and Debt6 794 000
Cash flow (NOK)2022
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold0
Salary Costs0
Depreciation7 000
Impairment0
Expenditure83 000
Operating Profit−82 000
Financial Income0
Financial Costs2 000
Financial Balance−2 000
Dividends0
Net Income−62 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets23 000
Real Eastate3 200 000
Machinery and Plant Facilities0
Fixtures318 000
Total Tangible Assets3 518 000
Total Fiancial Fixed Assets0
Total Fixed Assets3 541 000
Stock3 232 000
Total Investments0
Cash, Bank7 000
Total Current Assets3 253 000
Total Assets6 794 000
Total Equity19 000
Short-Term Group Debt0
Total Long-Term Debt3 620 000
Creditors697 000
Unpaid Taxes0
Dividends0
Other Current Debt−2 000
Total Current Debt3 155 000
Total Equity and Debt6 794 000
Financial indicators2022
Return on Equity−326,32 %
Debt-to-Equity Ratio190,53
Operating Profit Margin-
Current Ratio1,03
Quick Ratio−42,25
Equity Ratio0
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English